Provigil Package Insert

Pharmacy Medical Necessity Guidelines: Analeptic CNS ...
2 Pharmacy Medical Necessity Guidelines: Analeptic CNS Stimulants 1. Documentation the Member has had an office visit and has been re-assessed for this condition within the past year, and continued therapy with this medication is considered medically necessary ... Doc Retrieval

UnitedHealthcare Pharmacy Program Prior Authorization ...
Modafinil (Provigil*) and armodafinil (Nuvigil*) are wakefulness-promoting agents for oral administration. Both products are approved by the Food and Drug Administration (FDA) to improve wakefulness in patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea and shift work disorder. Modafinil has been shown ... Fetch Content

Page 1 Of 4 - AmeriHealth
SHIFT WORK SLEEP DISORDER (SWSD) Modafinil (Provigil®) is approved when all of the following inclusion criteria are met: zMember meets one of the following: o Documentation of a diagnosis of Shift Work Sleep Disorder with recommendation of modafinil (Provigil®) by a neurologist or sleep specialist ... Return Doc

Provigil (modafinil) - Anthem
*NOTE: The quantity limit for Provigil 200mg tablets can be increased from 200mg (30 tablets/30 days) to 400mg (60 tablets/30 days) after a trial of 200mg (30 tablets/30 days) per day with no success. According to the package insert, doses of 400mg per day given as a ... Retrieve Content

Aricept - HIGHLIGHTS OF PRESCRIBING INFORMATION
The recommended starting dosage of ARICEPT is 5 mg administered once per day in the evening, just prior to retiring. The maximum recommended dosage of ARICEPT in patients with mild to moderate Alzheimer’s disease is 10 mg per day. A dose of 10 mg should not be administered until patients have been on a daily dose of 5 mg for 4 to 6 weeks. ... Read Here

Medical Department Procedure Manual - Home - AvMed
3.0 Medical Department staff has access to the Medical Department Procedure Manual and receives notice from management when procedures are developed, revised, or archived: Provigil® (modafinil) [package insert]. Frazer, PA: Cephalon, Inc. July 2008. 2. ... Retrieve Document

Clinical Edit Criteria Proposal Provigil (Modafanil) And ...
Provigil 100 mg tablets 186 $160,655 Provigil 200 mg tablets 834 $897,726 Nuvigil 50 mg tablets 74 $15,584 Nuvigil 150 mg tablets 451 $229,978 Package Insert for Provigil, Cephalon, Inc., Frazier, PA 19355; 2010. 4. ... Access Full Source

Last Review Status/Date - FEP Blue
Provigil has been found effective in the treatment of multiple sclerosis fatigue (3). Modafinil is a unique wake-promoting agent that is chemically distinct from traditional stimulants. ... Access Full Source

Topical Pain Patches - Blue Cross And Blue Shield Of Louisiana
Topical Pain Patches Policy # 00365 Original Effective Date: 10/16/2013 Current Effective Date: 10/17/2018 ©2018 Blue Cross and Blue Shield of Louisiana Blue Cross and Blue Shield of Louisiana is an independent licensee of the Blue Cross and Blue Shield Association and incorporated as Louisiana Health Service & Indemnity Company. ... Retrieve Content

Risperidone - Wikipedia
Risperidone, sold under the trade name Risperdal among others, is an antipsychotic medication. It is mainly used to treat schizophrenia, bipolar disorder, and irritability in people with autism. It is taken either by mouth or by injection into a muscle. The injectable version is long acting and lasts for about two weeks. ... Read Article

1194 Fall PnT - IntermountainPhysician
Provigil (modafinil) now share the same indications. These products are FDA indicated to improve wakefulness in patients who have excessive sleepiness associated with narcolepsy, Shift Work Provigil [package insert]. Frazer, PA: Cephalon, Inc; 2008 March. ... Doc Viewer

Supply Limits May Be In Place. - Healthplanofnevada.com
Provigil (modafinil) and Nuvigil (armodafinil) are wakefulness-promoting agents for oral administration. Both products are approved by the Food and Drug Administration (FDA) to improve wakefulness in patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder. Provigil has ... View This Document

Cli Inniccaall Ediitt ICCrritteerriiaa PPrrooppoossaall Drug ...
Is a branded drug product indicated for excessive daytime sleepiness and cataplexy in patients with narcolepsy. Narcolepsy is not rare, but it is an ... Fetch This Document

Package Leaflet: Information For The Patient Imnovid 1 Mg ...
Package leaflet: Information for the patient Imnovid 1 mg hard capsules Imnovid 2 mg hard capsules Imnovid 3 mg hard capsules Imnovid 4 mg hard capsules pomalidomide This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. ... Document Retrieval

Summary Of DDMAC Enforcement Correspondence March 2007
The package insert, moreover, contains a precaution about the effect of Provigil on the central nervous system and cautions patients about operating an automobile while taking Provogil. ... Return Document

HIGHLIGHTS OF PRESCRIBING INFORMATION Important ...
Xyrem is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy (1). ... Fetch Document

PRIOR AUTHORIZATION CRITERIA - Caremark
Provigil is indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorder. In OSA, Provigil is indicated as an adjunct to standard treatment(s) for the underlying obstruction. ... Access Content

When Used With - Gilead.com
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE RANEXA® is indicated for the treatment of chronic angina. RANEXA may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor ... Document Retrieval

HIGHLIGHTS OF PRESCRIBING INFORMATION - Aptiom
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE APTIOM is indicated for the treatment of partial-onset seizures in patients 4 years of age and older. ... Retrieve Full Source